[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566588":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":23,"responsibleParty":44,"collaborators":7,"id":48,"slug":7,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Heinrich-Heine University, Duesseldorf","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Frederik Lars Giesel, Prof. Dr., Medical Doctor","Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf","STUDY_CHAIR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Emil Novruzov, Medical Doctor","CONTACT","(+49)211 8118540","Emil.Novruzov@med.uni-duesseldorf.de",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Eduards Mamlins, Medical Doctor","(+49)211 8108069","eduards.mamlins@med.uni-duesseldorf.de",[24],{"facility":11,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Düsseldorf","North Rhine-Westphalia","40225","Germany","DE",{"type":32,"coordinates":33},"Point",[34,35],6.77927,51.22319,{"lat":35,"lon":34},[38,42,43],{"name":39,"role":16,"phone":7,"phoneExt":40,"email":41},"Frederik Lars Giesel, Univ.-Prof. Dr. med.","(+49)81 18540","frederik.giesel@med.uni-duesseldorf.de",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},{"name":15,"role":16,"phone":7,"phoneExt":7,"email":7},{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Dr. med. Emil Novruzov","Board Certified Nuclear medicine Physician","100566588",false,"NCT06657131","Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer","Diagnostic Performance and Clinical Impact of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer: a Real-World Evidence from a Monocentric, Prospective Observational Phase-4-Trial","[18F]PSMA-1007","Inclusion Criteria:\n\n* Informed Consent\n* Conduct of \\[18F\\]PSMA-1007 PET Imaging in the context of regular clinical care\n\nExclusion Criteria:\n\n* Technical Flaws in the acquisition protocol","MALE","18 Years",{"count":58,"type":59},250,"ESTIMATED","OBSERVATIONAL","Following numerous retrospective studies and Phase-3-Studies with promising results, \\[18F\\]PSMA-1007 has been approved by european authorities. Therefore, it is a growing deployment of this diagnostic method anticipated. This study aims to investigate the diagnostic performance and clinical impact in a real-world-evidence in the context of regular clinical care. The evidence generated by this approach is supposed to assist in optimizing the management of prostate cancer patients.",[63,64,65],"Prostate Cancer After a Radical Treatment","Biochemical Recurrence of Malignant Neoplasm of Prostate","Biochemical Persistence of Prostate Cancer",[67,68,69,53,70],"prostate cancer","biochemical recurrence","18F-PSMA-1007","biochemical persistence","2025-01-16",{"date":73,"type":74},"2025-01-17","ACTUAL",{"date":76,"type":74},"2024-11-01",{"date":78,"type":59},"2028-11-30",{"name":5,"class":6},1]